Shreya Badhrinarayanan, MD

Dr. Shreya Badhrinarayanan is a member of Triage Cancer's Scientific Advisory Council and is the Medical Director for Clinical Development Oncology at Genentech, a subsidiary of Roche. In this role, she provides strategic direction for the development of new Immuno- Oncology drugs by leading cross-functional teams and conducting medical monitoring of clinical trials.

Prior to her current position, she served as a Physician with the National Health Service (NHS) in the UK, where she made significant contributions to clinical and research initiatives. During her time there, she also played an active role in the RECOVERY Trial, the world's largest clinical trial for COVID-19 treatments.

Thriving in the field of medical leadership and management, Dr. Badhrinarayanan received the Edward Jenner Award from the NHS Leadership Academy. She has helped shape early-stage digital health and biotechnology startups in her capacity as a scientific advisor at the UCSF Health Hub. To further her passion for teaching, she served as an Honorary Lecturer in Medical Education and Simulation at the University of Adelaide Medical School, Australia. Her wide range of interests varies from AI in health care to D&I initiatives that have been embodied through her contributions to print and media as well as at conferences across the globe. In addition, she is the editor/reviewer of numerous high-impact journals including the British Medical Journal.

For her work and commitment towards public health, Dr. Badhrinarayanan was elected as a Fellow of the Royal Society of Public Health, UK. She received her medical degree from Brighton and Sussex Medical School, UK with numerous accolades. In her spare time, she volunteers as a part of the UCSF medical team supporting sporting events across the San Francisco Bay Area.